Primary Biliary Cirrhosis - Pipeline Insight, 2018
SKU ID :DEL-11471889 | Published Date: 01-Jan-2018 | No. of pages: 50Description
TOC
1. Report Introduction
2. Primary Biliary Cirrhosis Overview
3. Pipeline Therapeutics
• An Overview of Pipeline Products for Primary Biliary Cirrhosis
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
7. Therapeutic Assessment
• Assessment by Route of Administration
• Assessment by Stage and Route of Administration
• Assessment by Molecule Type
• Assessment by Stage and Molecule Type
8. Inactive Products
8.1 Drug Name : Company Name
• Product Description
• Research and Development
• Product Development Activities
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Tables & Figures
Table 1: Total Products for Primary Biliary Cirrhosis
Table 2: Products in Clinical Stage
Table 3: Products in Non-clinical Stage
Table 4: Assessment by Route of Administration
Table 5: Assessment by Stage and Route of Administration
Table 6: Assessment by Molecule Type
Table 7: Assessment by Stage and Molecule Type
Table 8: Inactive Products
Figure 1: Total Products for Primary Biliary Cirrhosis
Figure 2: Products in Clinical Stage
Figure 3: Products in Non-clinical Stage
Figure 4: Assessment by Route of Administration
Figure 5: Assessment by Stage and Route of Administration
Figure 6: Assessment by Molecule Type
Figure 7: Assessment by Stage and Molecule Type
Figure 8: Inactive Products
Companies
Albireo Pharma Inc
Arena Pharmaceuticals Inc
CymaBay Therapeutics Inc
Eisai Co Ltd
Enanta Pharmaceuticals Inc
Genfit SA
GenKyoTex SA
Gilead Sciences Inc
GlaxoSmithKline Plc
Intercept Pharmaceuticals Inc
MediGene AG
NGM Biopharmaceuticals Inc
Novartis AG
Retrophin Inc
Shire Plc
& list continues…
- PRICE
-
$1250$4000